Cervical cancer is the fourth most common female cancer worldwide and results in over 300
000 deaths globally. The causative agent of cervical cancer is persistent infection with high …

Human papillomaviruses (HPV) are the first viruses to have been acknowledged to prompt
carcinogenesis, and they are linked with cancers of the uterine cervix, anogenital tumors …

Cervical cancer is a worldwide disease that constitutes a significant public health problem,
especially in developing countries, not only due to its high incidence but also because the …

The prognosis of patients with metastatic cervical cancer is poor with a median survival of 8–
13 months. Despite the potency of chemotherapeutic drugs, this treatment is rarely curative …

Cervical cancer is an aggressive type of cancer affecting women worldwide. Many affected
individuals rely on smear tests for the diagnosis, surgery, chemotherapy, or radiation for their …

Human papillomaviruses (HPVs) are small double‐stranded circular DNA viruses with 8 kb
genomes. So far, more than 150 HPVs have been identified, and 12 types of HPVs have …

The immune response is a key factor in the fight against HPV infection and related cancers,
and thus, HPV is able to promote immune evasion through the expression of oncogenes. In …

Health systems worldwide consider cancer a disease that causes the highest number of
deaths per year. The low efficacy of current cancer therapies has led other areas of science …

Cervical cancer is a huge worldwide health burden, impacting women in impoverished
nations in particular. Traditional therapeutic approaches, such as surgery, radiation therapy …

Drug repurposing represents an alternative therapeutic strategy to cancer treatment. The
potent anti-cancer activities of a FDA-approved anthelminthic drug niclosamide have been …